γδ T cells in hematological malignancies: mechanisms and therapeutic strategies
Authors:
Open Access
- 11 December 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Blood Science
- Vol. 7 (1) , e00213
Abstract
γδ T cells are a unique subset of lymphocytes with both innate and adaptive features. They recognize and eradicate various hematological malignancies through different mechanisms, employing factors including γδ TCR, NKR, NKG2D, TRAIL, and perforin/granzyme. They also modulate other immune cells to enhance their antitumor activity. Moreover, γδ T cells have potent antiviral functions after hematopoietic stem cell transplantation (HSCT), which may improve the outcome of patients with hematological malignancies. In this review, we summarize the current knowledge on γδ T cell biology and function in hematological malignancies and HSCT complications. We also discuss the challenges and limitations of the clinical application of γδ T cells, such as their low frequency in peripheral blood and heterogeneity among different subsets. We then highlight some promising strategies for γδ T cell-based therapy, such as using agonist antibodies, cell engagers, or genetic modification technology. Furthermore, we review the recent clinical trials evaluating the safety and efficacy of γδ T-cell therapy in different hematological malignancies. In conclusion, γδ T cells represent a promising immunotherapeutic tool for hematological malignancies that deserves further exploration.Keywords
This publication has 103 references indexed in Scilit:
- CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards Vδ2+ T cell cytotoxicityAnnals of Hematology, 2022
- Hepatocellular carcinoma‐infiltrating γδ T cells are functionally defected and allogenic Vδ2+ γδ T cell can be a promising complementClinical and Translational Medicine, 2022
- Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma modelsClinical & Translational Immunology, 2022
- Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft‐versus‐host disease after allogeneic hematopoietic stem cell transplantationHematological Oncology, 2015
- Gamma Delta T Cell Reconstitution Is Associated with Fewer Infections and Improved Event-Free Survival after Hematopoietic Stem Cell Transplantation for Pediatric LeukemiaTransplantation and Cellular Therapy, 2015
- Neutrophils suppress γδ T‐cell functionEuropean Journal of Immunology, 2013
- Functional development of γδ T cellsEuropean Journal of Immunology, 2013
- Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinomaCancer Immunology, Immunotherapy, 2011
- Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumabInternational Journal of Cancer, 2008
- Structure, organization, and somatic rearrangement of T cell gamma genesCell, 1985